Lupin Ltd. (LUPIN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 641789,
    "name": "Lupin",
    "stock_name": "Lupin",
    "full_name": "Lupin Ltd.",
    "name_url": "stocks-analysis/lupin",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,267.00",
    "chg": 51.4,
    "chgp": "2.32%",
    "dir": 1,
    "prev_price": "2,215.60",
    "mcapval": "103,650.84 Cr",
    "mcap": "Mid Cap",
    "scripcode": 500257,
    "symbol": "LUPIN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE326A01037",
    "curr_date": "May 14",
    "curr_time": "",
    "bse_nse_vol": "9.57 lacs",
    "exc_status": "Active",
    "traded_date": "May 14, 2026",
    "traded_date_str": "2026 05 14",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lupin-641789-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MS",
      "url": "https://www.marketsmojo.com/mojostocks#!#top10",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lupin-641789-1&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Lupin Ltd. Sees Significant Open Interest Surge Signalling Renewed Market Optimism",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-significant-open-interest-surge-signalling-renewed-market-optimism-3987594",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LupinLtd_oi_spurts_by_underlying_3987594.png",
        "date": "2026-05-12 12:00:12",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, reflecting heightened market activity and shifting investor positioning. The stock outperformed its sector and broader indices on 12 May 2026, signalling renewed bullish sentiment amid evolving volume and price dynamics."
      },
      {
        "title": "Lupin Ltd. Sees Sharp Open Interest Surge Signalling Renewed Market Optimism",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-sharp-open-interest-surge-signalling-renewed-market-optimism-3987539",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LupinLtd_oi_spurts_by_underlying_3987539.png",
        "date": "2026-05-12 11:00:11",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, reflecting heightened market participation and potential directional bets. The stock’s latest open interest rose by 17.74% to 56,371 contracts, up from 47,878 previously, signalling increased investor interest amid a backdrop of mixed price action and sectoral trends."
      },
      {
        "title": "Lupin Ltd. Sees Sharp Open Interest Surge Signalling Renewed Market Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-sharp-open-interest-surge-signalling-renewed-market-interest-3987133",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LupinLtd_oi_spurts_by_underlying_3987133.png",
        "date": "2026-05-12 10:00:11",
        "description": "Lupin Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, reflecting a shift in market positioning and investor sentiment. The 17.9% increase in OI alongside rising volumes suggests heightened speculative activity and potential directional bets on the stock’s near-term trajectory."
      },
      {
        "title": "Lupin Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3986487",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LupinLtd_technicaldot_3986487.png",
        "date": "2026-05-12 08:04:52",
        "description": "Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent 5.56% decline in its share price to ₹2,245.65 on 12 May 2026, the stock’s longer-term technical indicators and fundamental mojo score suggest a cautiously optimistic outlook for investors."
      },
      {
        "title": "Lupin Ltd. Sees Sharp Open Interest Surge Amid Volatile Trading",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-sharp-open-interest-surge-amid-volatile-trading-3985764",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LupinLtd_oi_spurts_by_underlying_3985764.png",
        "date": "2026-05-11 15:00:09",
        "description": "Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 19.5% surge in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent price underperformance. This development reflects evolving market positioning and potential directional bets amid a backdrop of mixed technical signals and rising investor participation."
      },
      {
        "title": "Lupin Ltd. Sees Sharp Open Interest Surge Amid Volatile Derivatives Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-sharp-open-interest-surge-amid-volatile-derivatives-activity-3985726",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LupinLtd_oi_spurts_by_underlying_3985726.png",
        "date": "2026-05-11 14:00:08",
        "description": "Lupin Ltd., a mid-cap pharmaceutical heavyweight, experienced a notable 17.3% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent price underperformance. This surge in open interest, coupled with volume patterns and shifting investor positioning, offers critical insights into potential directional bets and market sentiment for the stock."
      },
      {
        "title": "Lupin Ltd. Sees Sharp Open Interest Surge Amid Derivatives Market Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-sharp-open-interest-surge-amid-derivatives-market-activity-3985687",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LupinLtd_oi_spurts_by_underlying_3985687.png",
        "date": "2026-05-11 13:00:07",
        "description": "Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a notable 16.2% increase in open interest (OI) in its derivatives segment on 11 May 2026, signalling heightened market activity despite the stock’s recent price underperformance. This surge in OI, coupled with volume patterns and shifting investor positioning, offers critical insights into potential directional bets and market sentiment surrounding the stock."
      },
      {
        "title": "Lupin Ltd. Sees Sharp Open Interest Surge Amid Volatile Derivatives Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-sharp-open-interest-surge-amid-volatile-derivatives-activity-3985619",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LupinLtd_oi_spurts_by_underlying_3985619.png",
        "date": "2026-05-11 12:00:07",
        "description": "Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the stock’s derivatives market shows signs of increased speculative interest, raising questions about potential directional bets and future price movements."
      },
      {
        "title": "Lupin Ltd. Sees Sharp Open Interest Surge Amidst Volatile Trading",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-sharp-open-interest-surge-amidst-volatile-trading-3985559",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LupinLtd_oi_spurts_by_underlying_3985559.png",
        "date": "2026-05-11 11:00:08",
        "description": "Lupin Ltd., a mid-cap pharmaceutical heavyweight, has witnessed a notable surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the stock’s derivatives market reveals complex directional bets that merit close attention from traders and investors alike."
      }
    ],
    "total": 678,
    "sid": "641789",
    "stock_news_url": "https://www.marketsmojo.com/news/lupin-641789"
  },
  "announcements": [
    {
      "details": "Lupin Limited has informed the Exchange regarding Grant of 149578 Options.",
      "source": "NSE",
      "caption": "Lupin Limited - ESOP/ESOS/ESPS",
      "datetime": "05-Dec-2019"
    },
    {
      "details": "Lupin Limited has informed the Exchange regarding a press release dated December 03, 2019, titled \"Lupin Foundation Wins Award for Excellence in Corporate Social Responsibility at India",
      "source": "NSE",
      "caption": "Lupin Limited - Press Release",
      "datetime": "03-Dec-2019"
    },
    {
      "details": "Lupin Limited has informed the Exchange regarding allotment of 60495 Equity Shares under ESOP",
      "source": "NSE",
      "caption": "Lupin Limited - Allotment of ESOP/ESPS",
      "datetime": "28-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has declared <strong>600%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>2:10</strong> stock split, ex-date: 27 Aug 10",
          "dt": "2010-08-27",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 11 Aug 06",
          "dt": "2006-08-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Lupin Ltd. Sees Significant Open Interest Surge Signalling Renewed Market Optimism

2026-05-12 12:00:12

Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, reflecting heightened market activity and shifting investor positioning. The stock outperformed its sector and broader indices on 12 May 2026, signalling renewed bullish sentiment amid evolving volume and price dynamics.

Read full news article

Lupin Ltd. Sees Sharp Open Interest Surge Signalling Renewed Market Optimism

2026-05-12 11:00:11

Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, reflecting heightened market participation and potential directional bets. The stock’s latest open interest rose by 17.74% to 56,371 contracts, up from 47,878 previously, signalling increased investor interest amid a backdrop of mixed price action and sectoral trends.

Read full news article

Lupin Ltd. Sees Sharp Open Interest Surge Signalling Renewed Market Interest

2026-05-12 10:00:11

Lupin Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, reflecting a shift in market positioning and investor sentiment. The 17.9% increase in OI alongside rising volumes suggests heightened speculative activity and potential directional bets on the stock’s near-term trajectory.

Read full news article

Lupin Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-12 08:04:52

Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent 5.56% decline in its share price to ₹2,245.65 on 12 May 2026, the stock’s longer-term technical indicators and fundamental mojo score suggest a cautiously optimistic outlook for investors.

Read full news article

Lupin Ltd. Sees Sharp Open Interest Surge Amid Volatile Trading

2026-05-11 15:00:09

Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 19.5% surge in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent price underperformance. This development reflects evolving market positioning and potential directional bets amid a backdrop of mixed technical signals and rising investor participation.

Read full news article

Lupin Ltd. Sees Sharp Open Interest Surge Amid Volatile Derivatives Activity

2026-05-11 14:00:08

Lupin Ltd., a mid-cap pharmaceutical heavyweight, experienced a notable 17.3% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent price underperformance. This surge in open interest, coupled with volume patterns and shifting investor positioning, offers critical insights into potential directional bets and market sentiment for the stock.

Read full news article

Lupin Ltd. Sees Sharp Open Interest Surge Amid Derivatives Market Activity

2026-05-11 13:00:07

Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a notable 16.2% increase in open interest (OI) in its derivatives segment on 11 May 2026, signalling heightened market activity despite the stock’s recent price underperformance. This surge in OI, coupled with volume patterns and shifting investor positioning, offers critical insights into potential directional bets and market sentiment surrounding the stock.

Read full news article

Lupin Ltd. Sees Sharp Open Interest Surge Amid Volatile Derivatives Activity

2026-05-11 12:00:07

Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the stock’s derivatives market shows signs of increased speculative interest, raising questions about potential directional bets and future price movements.

Read full news article

Lupin Ltd. Sees Sharp Open Interest Surge Amidst Volatile Trading

2026-05-11 11:00:08

Lupin Ltd., a mid-cap pharmaceutical heavyweight, has witnessed a notable surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent price decline, the stock’s derivatives market reveals complex directional bets that merit close attention from traders and investors alike.

Read full news article

View All News